Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study

Peter G. Lawlor, Bruno Gagnon, Isabelle L. Mancini, Jose L. Pereira, John Hanson, Maria E. Suarez-Almazor, Eduardo D. Bruera

Research output: Contribution to journalArticlepeer-review

641 Scopus citations

Abstract

Context: Delirium impedes communication and contributes to symptom distress in patients with advanced cancer. There are few prospective data on the reversal of delirium in this population. Objectives: To evaluate the occurrence, precipitating factors, and reversibility of delirium in patients with advanced cancer. Design: Prospective serial assessment in a consecutive cohort of 113 patients with advanced cancer. Precipitating factors were examined using standardized criteria; 104 patients met eligibility criteria. Setting: Acute palliative care unit in a university-affiliated teaching hospital. Main Outcome Measures: Delirium occurrence and reversal rates, duration, and patient survival. Strengths of association of various precipitating factors with reversal were expressed as hazard ratios (HRs) in univariate and multivariate analyses. Results: On admission, delirium was diagnosed in 44 patients (42%), and of the remaining 60, delirium developed in 27 (45%). Reversal of delirium occurred in 46 (49%) of 94 episodes in 71 patients. Terminal delirium occurred in 46 (88%) of the 52 deaths. In univariate analysis, psychoactive medications, predominantly opioids (HR, 8.85; 95% confidence interval [CI], 2.13-36.74), and dehydration (HR, 2.35; 95% CI, 1.20-4.62) were associated with reversibility. Hypoxic encephalopathy (HR, 0.39; 95% CI, 0.19-0.80) and metabolic factors (HR, 0.44; 95% CI, 0.21- 0.91) were associated with non-reversibility. In multivariate analysis, psychoactive medications (HR, 6.65; 95% CI, 1.49-29.62), hypoxic encephalopathy (HR, 0.32; 95% CI, 0.15-0.70), and non-respiratory infection (HR, 0.23; 95% CI, 0.08-0.64) had independent associations. Patients with delirium had poorer survival rates than controls (P<.001). Conclusions: Delirium is a frequent, multifactorial complication in advanced cancer. Despite its terminal presentation in most patients, delirium is reversible in approximately 50% of episodes. Delirium precipitated by opioids and other psychoactive medications and dehydration is frequently reversible with change of opioid or dose reduction, discontinuation of unnecessary psychoactive medication, or hydration, respectively.

Original languageEnglish (US)
Pages (from-to)786-794
Number of pages9
JournalArchives of Internal Medicine
Volume160
Issue number6
DOIs
StatePublished - Mar 27 2002

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study'. Together they form a unique fingerprint.

Cite this